Home Cart Sign in  
Chemical Structure| 103766-25-2 Chemical Structure| 103766-25-2

Structure of Gimeracil
CAS No.: 103766-25-2

Chemical Structure| 103766-25-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gimeracil is an inhibitor of dihydropyrimidine dehydrogenase (DPYD), which degrades pyrimidine including 5-fluorouracil in the blood and inhibits homologous recombination.

Synonyms: Gimestat; CDHP; chlorodihydroxypyridine. Abbreviation: CDHP.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gimeracil

CAS No. :103766-25-2
Formula : C5H4ClNO2
M.W : 145.54
SMILES Code : O=C1C=C(O)C(Cl)=CN1
Synonyms :
Gimestat; CDHP; chlorodihydroxypyridine. Abbreviation: CDHP.
MDL No. :MFCD08458352
InChI Key :ZPLQIPFOCGIIHV-UHFFFAOYSA-N
Pubchem ID :54679224

Safety of Gimeracil

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Gimeracil

RTK

Isoform Comparison

Biological Activity

Target
  • Dehydrogenase

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice NAFLD models Dietary administration 260 mg gimeracil per kg diet 12 weeks Inhibition of pyrimidine catabolism to protect against liver fibrosis Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2217543120
Sprague-Dawley rats Oral 1.45 mg/kg Single dose To evaluate the effect of SDT on the pharmacokinetics of S-1, results showed that repeated doses of SDT significantly decreased the plasma levels of 5-FU, associated with reduced absorption of gimeracil. Molecules. 2017 Sep 7;22(9):1488

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.87mL

1.37mL

0.69mL

34.35mL

6.87mL

3.44mL

68.71mL

13.74mL

6.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories